In Vitro antileishmanial properties of neutron-irradiated meglumine antimoniate
Borborema, Samanta Etel Treiger; Andrade Junior, Heitor Franco de; Osso Junior, João Alberto; Nascimento, Nanci do.
Braz. arch. biol. technol
; 48(spe2): 63-68, Oct. 2005. graf, tab
Artigo em Inglês | LILACS | ID: lil-448890
Documentos relacionados
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.
Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach.
Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate.
[Treatment of visceral leishmaniasis in children].
Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases.
[Current situation and future of antileishmanial therapy in Colombia].
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.